Smart Inhalers Market to Reach $12.1 Billion by 2030

Industry
โดย GlobeNewswire·Read original
Summary · why it matters

The global smart inhalers market is projected to grow from $5.2 billion in 2024 to $12.1 billion by 2030, a compound annual growth rate of 15.4%, according to a new report from BCC Research. The expansion is driven by poor medication adherence among asthma and COPD patients, with compliance rates often below 50%, leading to preventable hospitalizations and emergency visits. North America holds the largest market share, supported by digital health infrastructure and new CMS Remote Therapeutic Monitoring reimbursement codes. Key players include AstraZeneca, GSK plc, Novartis AG, Boehringer Ingelheim International GmbH, Adherium, and Amiko Digital Health Ltd.

Impact on stocks 3

Biotech & Genomic Medicine▲ · 3 stocks
AstraZeneca PLC
AZN
▲ PositiveDemandrelevance

Smart inhalers market growth driven by poor adherence, benefiting key player AstraZeneca.

GSK plc
GSK
▲ PositiveDemandrelevance

Smart inhalers market growth driven by poor adherence, benefiting key player GSK.

Novartis AG
NOVN
▲ PositiveDemandrelevance

Smart inhalers market growth driven by poor adherence, benefiting key player Novartis.

Off-coverage companies 2

Adherium LimitedPrivate▲ Positive
Demandrelevance

Adherium is a pure-play smart inhaler company, directly benefiting from market growth.

Amiko Digital HealthPrivate▲ Positive
Demandrelevance

Amiko is a pure-play smart inhaler company, directly benefiting from market growth.

© 2026 MarketDXNews